Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Unaudited ....
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India has informed the stock exchanges that its Board of Directors will meet on Wednesday, 12 November 2025. The main agenda is to consider and approve the Unaudited Financial Results for the quarter and nine months ended 30 September 2025. The company has also confirmed that the trading window for designated persons remains closed from 1 October 2025 to 14 November 2025 in line with its insider trading code. This is a routine regulatory filing under SEBI Listing Regulations, and no financial numbers have been disclosed in this intimation.
No direct impact on the stock from this filing as it only notifies an upcoming board meeting. Investors should watch for the actual Q2 FY26 results on or after 12 November 2025 for insights into revenue, profit and margins. The closed trading window means insiders cannot trade until after results are published.